Prasugrel Delay Shifts Focus To Possible August Advisory Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA extends user fee date for the novel anti-platelet drug to Sept. 26.
You may also be interested in...
Prasugrel Delay Could Extend Well Into 2009; FDA Eyes February Cmte. Review
It looks like FDA's decision on Lilly's anti-clotting drug prasugrel won't come before March 2009 at the earliest
Prasugrel Delay Could Extend Well Into 2009; FDA Eyes February Cmte. Review
It looks like FDA's decision on Lilly's anti-clotting drug prasugrel won't come before March 2009 at the earliest
Prasugrel Round Two: Is FDA Approval In Sight?
FDA action on Eli Lilly/Daiichi Sankyo’s clot buster anticipated Sept. 26.